As of 2025-07-12, the Relative Valuation of Immunovant Inc (IMVT) is (52.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.13 USD, the upside of Immunovant Inc based on Relative Valuation is -392.3%.
The range of the Relative Valuation is (34.60) - (65.29) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.6x - 26.8x | 20.2x |
| Forward P/E multiples | 14.2x - 32.4x | 23.3x |
| Fair Price | (34.60) - (65.29) | (52.99) |
| Upside | -290.8% - -460.1% | -392.3% |
| Date | P/E |
| 2025-07-11 | -7.44 |
| 2025-07-10 | -7.18 |
| 2025-07-09 | -7.10 |
| 2025-07-08 | -6.93 |
| 2025-07-07 | -6.74 |
| 2025-07-03 | -6.96 |
| 2025-07-02 | -6.90 |
| 2025-07-01 | -6.63 |
| 2025-06-30 | -6.57 |
| 2025-06-27 | -6.61 |
| 2025-06-26 | -6.73 |
| 2025-06-25 | -6.46 |
| 2025-06-24 | -6.57 |
| 2025-06-23 | -6.35 |
| 2025-06-20 | -6.49 |
| 2025-06-18 | -6.51 |
| 2025-06-17 | -6.28 |
| 2025-06-16 | -6.36 |
| 2025-06-13 | -6.43 |
| 2025-06-12 | -6.54 |
| 2025-06-11 | -6.63 |
| 2025-06-10 | -6.87 |
| 2025-06-09 | -6.69 |
| 2025-06-06 | -6.88 |
| 2025-06-05 | -6.58 |
| 2025-06-04 | -6.30 |
| 2025-06-03 | -6.34 |
| 2025-06-02 | -6.33 |
| 2025-05-30 | -6.10 |
| 2025-05-29 | -6.11 |
| 2025-05-28 | -5.79 |
| 2025-05-27 | -5.87 |
| 2025-05-23 | -5.94 |
| 2025-05-22 | -5.98 |
| 2025-05-21 | -5.91 |
| 2025-05-20 | -6.16 |
| 2025-05-19 | -6.03 |
| 2025-05-16 | -5.94 |
| 2025-05-15 | -5.71 |
| 2025-05-14 | -5.66 |
| 2025-05-13 | -5.75 |
| 2025-05-12 | -5.97 |
| 2025-05-09 | -5.75 |
| 2025-05-08 | -5.87 |
| 2025-05-07 | -5.70 |
| 2025-05-06 | -5.68 |
| 2025-05-05 | -6.25 |
| 2025-05-02 | -6.49 |
| 2025-05-01 | -6.53 |
| 2025-04-30 | -6.63 |